Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

582 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacologic Treatment of Noninfectious Uveitis.
Knickelbein JE, Armbrust KR, Kim M, Sen HN, Nussenblatt RB. Knickelbein JE, et al. Among authors: nussenblatt rb. Handb Exp Pharmacol. 2017;242:231-268. doi: 10.1007/164_2016_21. Handb Exp Pharmacol. 2017. PMID: 27848029
Emerging drugs for uveitis.
Larson T, Nussenblatt RB, Sen HN. Larson T, et al. Among authors: nussenblatt rb. Expert Opin Emerg Drugs. 2011 Jun;16(2):309-22. doi: 10.1517/14728214.2011.537824. Epub 2011 Jan 6. Expert Opin Emerg Drugs. 2011. PMID: 21210752 Free PMC article. Review.
Clinical trials in noninfectious uveitis.
Kim JS, Knickelbein JE, Nussenblatt RB, Sen HN. Kim JS, et al. Among authors: nussenblatt rb. Int Ophthalmol Clin. 2015 Summer;55(3):79-110. doi: 10.1097/IIO.0000000000000070. Int Ophthalmol Clin. 2015. PMID: 26035763 Free PMC article. Review.
Elevated CD1c+ Myeloid Dendritic Cell Proportions Associate With Clinical Activity and Predict Disease Reactivation in Noninfectious Uveitis.
Chen P, Urzua CA, Knickelbein JE, Kim JS, Li Z, Hannes S, Kuo D, Chaigne-Delalande B, Armbrust K, Tucker W, Liu B, Agrón E, Sen HN, Nussenblatt RB. Chen P, et al. Among authors: nussenblatt rb. Invest Ophthalmol Vis Sci. 2016 Apr;57(4):1765-72. doi: 10.1167/iovs.15-18357. Invest Ophthalmol Vis Sci. 2016. PMID: 27070110 Free PMC article.
Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration.
Nussenblatt RB, Thompson DJ, Li Z, Chan CC, Peterson JS, Robinson RR, Shames RS, Nagarajan S, Tang MT, Mailman M, Velez G, Roy C, Levy-Clarke GA, Suhler EB, Djalilian A, Sen HN, Al-Khatib S, Ursea R, Srivastava S, Bamji A, Mellow S, Sran P, Waldmann TA, Buggage RR. Nussenblatt RB, et al. J Autoimmun. 2003 Nov;21(3):283-93. doi: 10.1016/s0896-8411(03)00113-6. J Autoimmun. 2003. PMID: 14599854 Clinical Trial.
Gene expression profiling in autoimmune noninfectious uveitis disease.
Li Z, Liu B, Maminishkis A, Mahesh SP, Yeh S, Lew J, Lim WK, Sen HN, Clarke G, Buggage R, Miller SS, Nussenblatt RB. Li Z, et al. Among authors: nussenblatt rb. J Immunol. 2008 Oct 1;181(7):5147-57. doi: 10.4049/jimmunol.181.7.5147. J Immunol. 2008. PMID: 18802119 Free PMC article.
Infliximab for the treatment of active scleritis.
Sen HN, Sangave A, Hammel K, Levy-Clarke G, Nussenblatt RB. Sen HN, et al. Among authors: nussenblatt rb. Can J Ophthalmol. 2009 Jun;44(3):e9-e12. doi: 10.3129/i09-061. Can J Ophthalmol. 2009. PMID: 19506593 Free PMC article. Clinical Trial.
582 results